يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Geneviève Boileau-Jolimoy"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: 'Health across Generations' Team [Villejuif], Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Service de Cardiologie [CHU de Dijon], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Institut Gustave Roussy (IGR), Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, Institut Curie [Paris], Centre Alexis Vautrin [Vandoeuvre-lès-Nancy], Centre Paul Strauss, CRLCC Paul Strauss, Institut Claudius Regaud, Institut du Cancer de Montpellier (ICM), Institut Sainte Catherine [Avignon], Centre Hospitalier de Blois (CH Blois), Centre Hospitalier Régional d'Orléans (CHRO), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Polyclinique du Parc - Clinique Drevon [Dijon], Unicancer [Paris], This research was supported by the French Government under the 'Investment for the Future' program managed by the National Research Agency (ANR), grant n˚ ANR-10-COHO-0004 (FA) and by a Clinical Research Fellowship from the French government (EGK)., ANR-10-COHO-0004,CANTO,Etude des toxicités chroniques des traitements anticancéreux chez les patientes porteuses cancer(2010), Bodescot, Myriam, Cohortes - Etude des toxicités chroniques des traitements anticancéreux chez les patientes porteuses cancer - - CANTO2010 - ANR-10-COHO-0004 - COHO - VALID, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), Centre Hospitalier de Blois (CHB)

    المصدر: PLoS Medicine
    PLoS Medicine, Public Library of Science, 2019, 16 (12), pp.e1002989. ⟨10.1371/journal.pmed.1002989⟩
    PLoS Medicine, 2019, 16 (12), pp.e1002989. ⟨10.1371/journal.pmed.1002989⟩
    PLoS Medicine, Vol 16, Iss 12, p e1002989 (2019)

    مصطلحات موضوعية: Physiology, Epidemiology, Cancer Treatment, Blood Pressure, 030204 cardiovascular system & hematology, Overweight, Vascular Medicine, Body Mass Index, Cohort Studies, Endocrinology, 0302 clinical medicine, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Breast Tumors, Medicine and Health Sciences, Medicine, Anthracyclines, 030212 general & internal medicine, 2. Zero hunger, Antibiotics, Antineoplastic, Pharmaceutics, Cancer Risk Factors, General Medicine, Middle Aged, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Physiological Parameters, Oncology, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Hypertension, Female, medicine.symptom, Research Article, Cohort study, Epirubicin, medicine.drug, Adult, Clinical Oncology, medicine.medical_specialty, Heart Diseases, Anthracycline, Endocrine Disorders, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Cancer Chemotherapy, 03 medical and health sciences, Breast cancer, Drug Therapy, [SDV.CAN] Life Sciences [q-bio]/Cancer, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Breast Cancer, Diabetes Mellitus, Humans, Chemotherapy, Obesity, Cardiotoxicity, business.industry, Body Weight, Biology and Life Sciences, Cancers and Neoplasms, Odds ratio, Trastuzumab, medicine.disease, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Medical Risk Factors, Metabolic Disorders, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Clinical Medicine, business, Body mass index

    وصف الملف: application/pdf